Insulin-like growth factor binding protein-3 expression is associated with growth stimulation of T47D human breast cancer cells: The role of altered epidermal growth factor signaling

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 4, 2004, Pages 1950-1956

  Butt, Alison J ^a   Martin, Janet L ^a   Dickson, Kristie A ^a   McDougall, Fiona ^a   Firth, Sue M ^a   Baxter, Robert C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; EPIDERMAL GROWTH FACTOR; PROTEIN KINASE INHIBITOR; SOMATOMEDIN BINDING PROTEIN 3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CANCER CELL; CARCINOGENICITY; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENETIC TRANSFECTION; GROWTH STIMULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MICE; MICE, NUDE; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; UP-REGULATION;

ANIMALIA;

EID: 1942536619     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030914     Document Type: Article

References (29)

1. Firth SM, Baxter RC 2002 Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854
2. De Mellow JS, Baxter RC 1988 Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I-stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Comm 156:199-204
3. Conover CA 1992 Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. Endocrinology 130: 3191-3199
4. Chen JC, Shao ZM, Sheikh MS, Hussain A, LeRoith D, Roberts CT, Fontana JA 1994 Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line. J Cell Physiol 158:69-78
5. Figueroa JA, Yee D 1992 The insulin-like growth factor binding proteins (IGFBPs) in human breast cancer. Breast Cancer Res Treat 22:81-90
6. Butt AJ, Williams AC 2001 IGFBP-3 and apoptosis - a licence to kill? Apoptosis 6:199-205
7. Butt AJ, Firth SM, King MA, Baxter RC 2000 Insulin-like growth factor binding protein-3 modulates expression of Bax and Bcl-2 and potentiates p53-independent radiation-induced apoptosis in human breast cancer cells. J Biol Chem 275:39174-39181
8. Butt AJ, Fraley KA, Firth SM, Baxter RC 2002 Insulin-like growth factor binding protein-3-induced growth inhibition and apoptosis do not require cell-surface binding and nuclear translocation in human breast cancer cells. Endocrinology 143:2693-2699
9. Oh Y, Muller HL, Pham H, Rosenfeld RG 1993 Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem 268:26045-26048
10. Schedlich LJ, Young TY, Firth SM, Baxter RC 1998 Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J Biol Chem 273:18347-18352
11. Liu B, Lee HY, Weinzimer SA, Powell DR, Clifford JL, Kurie JM, Cohen P 2000 Direct functional interactions between IGFBP-3 and retinoid X receptor-α regulate transcriptional signaling and apoptosis. J Biol Chem 275-33607-33613
12. Firth SM, Fanayan S, Benn D, Baxter RC 1998 Development of resistance to insulin-like growth factor binding protein-3 in transfected T47D breast cancer cells. Biochem Biophys Res Commun 246:325-329
13. Grill CJ, Sivaprasad U, Cohick WS 2002 Constitutive expression of IGF-binding protein-3 by mammary epithelial cells alters signaling through Akt and p70S6 kinase. J Mol Endocrinol 29:153-162
14. Martin JL, Baxter RC 1999 Oncogenic ras causes resistance to the growth inhibitor insulin-like growth factor binding protein-3 (IGFBP-3) in breast cancer cells. J Biol Chem 274:16407-16411
15. Martin JL, Weenink S, Baxter RC 2003 Insulin-like growth factor binding protein-3 potentiates EGF action in MCF-10A mammary epithelial cells: involvement of p44/42 and p38 MAP kinases. J Biol Chem 278:2969-2976
16. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M 1998 Circulating concentrations of IGF-I and risk of breast cancer. Lancet 351:1393-1396
17. Rocha RL, Hilsenbeck SG, Jackson JG, Vandenberg CL, Weng C, Lee AV, Figueroa JA, Yee D 1996 Correlation of insulin-like growth factor binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features. J Natl Cancer Inst 88:601-606
18. Rocha RL, Hilsenbeck SG, Jackson JG, Chen JC 1997 Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival. Clin Cancer Res 3:103-109
19. Yu H, Levesque MA, Khosravi MJ, Papanastasiou-Diamandi A, Clark GM, Diamandis EP 1996 Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer. Br J Cancer 74:1242-1247
20. Bouey-Bencteux E, Loison C, Pommery N, Houssin R, Hénichart JP 1998 Synthesis and antiproliferative properties of 4-aminoquinazoline derivatives as inhibitors of EGF-receptor-associated tyrosine kinase activity. Anticancer Drug Des 13:893-922
21. Baxter RC, Martin JL 1986 Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma. J Clin Invest 78:1504-1512
22. Delhanty PJD, Scott CD, Babu S, Baxter RC 2001 Acid-labile subunit regulation during the early stages of liver regeneration: implications for glucoregulation. Am J Physiol 280:E287-E295
23. Wraight CJ, Liepe IJ, White PJ, Hibbs AR, Werther GA 1998 Intranuclear localization of insulin-like growth factor binding protein-3 (IGFBP-3) during cell division in human keratinocytes. J Invest Dermatol 111:239-242
24. Perks CM, McCraig C, Holly JMP 2000 Differential insulin-like growth factor (IGF)-independent interactions of IGF binding protein-3 and IGF binding protein-5 on apoptosis in human breast cancer cells. Involvement of the mitochondria. J Cell Biochem 80:248-258
25. Clemmons DR, Camacho HC, Coronado E, Osbourne CK 1990 Insulin-like growth factor binding protein secretion by breast carcinoma cell lines: correlation with estrogen receptor status. Endocrinology 127:2679-2686
26. Benner SE, Clark GM, McGuire WL 1988 Steroid receptors, cellular kinetics and lymph node status as prognostic factors in breast cancer. Am J Med Sci 296:59-66
27. Hochscheid R, Jacques G, Wegmann B 2000 Transfection of human insulin-like growth factor-binding protein 3 gene inhibits cell growth and tumorigenicity: a cell culture model for lung cancer. J Endocrinol 166:553-563
28. Conover CA, Bale LK, Durham SK, Powell DR 2000 Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/Akt sensitivity. Endocrinology 141:3098-3103
29. Butt AJ, Dickson KA, McDougall F, Baxter RC 2003 Insulin-like growth factor binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo. J Biol Chem 278:29676-29685